160 related articles for article (PubMed ID: 9373127)
1. Chronic use of apraclonidine decreases its moderation of post-laser intraocular pressure spikes.
Chung HS; Shin DH; Birt CM; Kim C; Lee D; Levin DS; Hakimzadeh R; Juzych MS
Ophthalmology; 1997 Nov; 104(11):1921-5. PubMed ID: 9373127
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of apraclonidine 1% versus pilocarpine 4% for prophylaxis of intraocular pressure spike after argon laser trabeculoplasty.
Ren J; Shin DH; Chung HS; Birt CM; Glover BK; Juzych MS; Hughes BA; Kim C
Ophthalmology; 1999 Jun; 106(6):1135-9. PubMed ID: 10366082
[TBL] [Abstract][Full Text] [Related]
3. Apraclonidine 0.5% versus brimonidine 0.2% for the control of intraocular pressure elevation following anterior segment laser procedures.
Chevrier RL; Assalian A; Duperré J; Lesk MR
Ophthalmic Surg Lasers; 1999 Mar; 30(3):199-204. PubMed ID: 10100253
[TBL] [Abstract][Full Text] [Related]
4. Control of intraocular pressure elevations after argon laser trabeculoplasty: comparison of brimonidine 0.2% to apraclonidine 1.0%.
Barnes SD; Campagna JA; Dirks MS; Doe EA
Ophthalmology; 1999 Oct; 106(10):2033-7. PubMed ID: 10519604
[TBL] [Abstract][Full Text] [Related]
5. Brimonidine 0.2% versus apraclonidine 0.5% for prevention of intraocular pressure elevations after anterior segment laser surgery.
Chen TC; Ang RT; Grosskreutz CL; Pasquale LR; Fan JT
Ophthalmology; 2001 Jun; 108(6):1033-8. PubMed ID: 11382625
[TBL] [Abstract][Full Text] [Related]
6. Apraclonidine and anterior segment laser surgery. Comparison of 0.5% versus 1.0% apraclonidine for prevention of postoperative intraocular pressure rise.
Rosenberg LF; Krupin T; Ruderman J; McDaniel DL; Siegfried C; Karalekas DP; Grewal RK; Gieser DK; Williams R
Ophthalmology; 1995 Sep; 102(9):1312-8. PubMed ID: 9097768
[TBL] [Abstract][Full Text] [Related]
7. Perioperative medications for preventing temporarily increased intraocular pressure after laser trabeculoplasty.
Zhang L; Weizer JS; Musch DC
Cochrane Database Syst Rev; 2017 Feb; 2(2):CD010746. PubMed ID: 28231380
[TBL] [Abstract][Full Text] [Related]
8. Apraclonidine 0.5% versus 1% for controlling intraocular pressure elevation after argon laser trabeculoplasty.
Threlkeld AB; Assalian AA; Allingham RR; Shields MB
Ophthalmic Surg Lasers; 1996 Aug; 27(8):657-60. PubMed ID: 8858630
[TBL] [Abstract][Full Text] [Related]
9. Reversal of intraocular pressure increases with 0.5% apraclonidine after dilated fundus examination in patients with chronic open-angle glaucoma.
Nishimoto JH; Chang FW; Tang IH; Kolin T
J Am Optom Assoc; 1999 Apr; 70(4):233-9. PubMed ID: 10457699
[TBL] [Abstract][Full Text] [Related]
10. Effect of Apraclonidine and Diclofenac on Early Changes in Intraocular Pressure After Selective Laser Trabeculoplasty.
Thrane VR; Thrane AS; Bergo C; Halvorsen H; Krohn J
J Glaucoma; 2020 Apr; 29(4):280-286. PubMed ID: 32053556
[TBL] [Abstract][Full Text] [Related]
11. The effect of 0.25% apraclonidine in preventing intraocular pressure elevation after Nd:YAG laser posterior capsulotomy.
Simsek S; Ertürk H; Demirok A; Cinal A; Yasar T; Karadenizli C
Eur J Ophthalmol; 1998; 8(3):167-72. PubMed ID: 9793771
[TBL] [Abstract][Full Text] [Related]
12. Effect of topical apraclonidine on the frequency of intraocular pressure elevations after combined extracapsular cataract extraction and trabeculectomy.
Robin AL
Ophthalmology; 1993 May; 100(5):628-33. PubMed ID: 8098520
[TBL] [Abstract][Full Text] [Related]
13. The rarity of clinically significant rise in intraocular pressure after laser peripheral iridotomy with apraclonidine.
Lewis R; Perkins TW; Gangnon R; Kaufman PL; Heatley GA
Ophthalmology; 1998 Dec; 105(12):2256-9. PubMed ID: 9855156
[TBL] [Abstract][Full Text] [Related]
14. Early intraocular pressure response to laser trabeculoplasty 180 degrees without apraclonidine versus 360 degrees with apraclonidine.
Allf BE; Shields MB
Ophthalmic Surg; 1991 Sep; 22(9):539-42. PubMed ID: 1682861
[TBL] [Abstract][Full Text] [Related]
15. Apraclonidine and argon laser trabeculoplasty.
Holmwood PC; Chase RD; Krupin T; Rosenberg LF; Ruderman JM; Tallman BA; Brodstein DE; Chopra H; Goldenfeld M
Am J Ophthalmol; 1992 Jul; 114(1):19-22. PubMed ID: 1352428
[TBL] [Abstract][Full Text] [Related]
16. Brimonidine 0.15% versus apraclonidine 0.5% for prevention of intraocular pressure elevation after anterior segment laser surgery.
Chen TC
J Cataract Refract Surg; 2005 Sep; 31(9):1707-12. PubMed ID: 16246772
[TBL] [Abstract][Full Text] [Related]
17. Comparing brimonidine 0.2% to apraclonidine 1.0% in the prevention of intraocular pressure elevation and their pupillary effects following laser peripheral iridotomy.
Yuen NS; Cheung P; Hui SP
Jpn J Ophthalmol; 2005; 49(2):89-92. PubMed ID: 15838723
[TBL] [Abstract][Full Text] [Related]
18. Influence of apraclonidine and pilocarpine alone and in combination on post laser trabeculoplasty pressure rise.
Dapling RB; Cunliffe IA; Longstaff S
Br J Ophthalmol; 1994 Jan; 78(1):30-2. PubMed ID: 7906539
[TBL] [Abstract][Full Text] [Related]
19. Brinzolamide 1% versus apraclonidine 0.5% to prevent intraocular pressure elevation after neodymium:YAG laser posterior capsulotomy.
Unal M; Yücel I; Akar Y
J Cataract Refract Surg; 2006 Sep; 32(9):1499-502. PubMed ID: 16931262
[TBL] [Abstract][Full Text] [Related]
20. Topical apraclonidine hydrochloride in eyes with poorly controlled glaucoma. The Apraclonidine Maximum Tolerated Medical Therapy Study Group.
Robin AL; Ritch R; Shin D; Smythe B; Mundorf T; Lehmann RP
Trans Am Ophthalmol Soc; 1995; 93():421-38; discussion 439-41. PubMed ID: 8719690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
